Skip to main content
. 2024 Dec 20;103(51):e40770. doi: 10.1097/MD.0000000000040770

Figure 5.

Figure 5.

Leave-one-out analysis of genetically HMGCR and APOB inhibition on VTE, DVT and PE. (A): (a) HMGCR inhibitor on VTE risk; (b) HMGCR inhibitor on DVT risk; (c) HMGCR inhibitor on PE risk. (B) (a) APOB inhibitor on VTE risk; (b) APOB inhibitor on DVT risk; (c) APOB inhibitor on PE risk. APOB = apolipoprotein B, DVT = deep vein thrombosis, HMGCR = 3-hydroxy-3-methylglutaryl-CoA reductase, PE = pulmonary embolism, SNP = single nucleotide polymorphism, VTE = venous thromboembolism.